Free webinar (via Google Meet)
Up to 1,000 registered participants
First 500 to log in will have interactive access (full participation)
Additional participants will join in view-only mode
Recording available exclusively to registered participants
Certificates of attendance provided to all live attendees (interactive and view-only)
Professor Jeffrey Everitt, DVM, DACVP, DACLAM, is a is Professor Emeritus in Pathology at Duke University School of Medicine, USA. A veterinary pathologist and laboratory animal medicine specialist, he trained at Cornell University, the University of Pennsylvania and the University of Illinois.
His career has included research, teaching and scientific advisory work across academia, industry and government, with particular expertise in toxicologic pathology, pulmonary and renal disease, digital pathology and the use of animal models in biomedical research and testing. He has served on numerous national and international scientific committees and currently sits on the NIH Board of Scientific Counselors for the Division of Translational Toxicology. For the past 15 years, a major focus of his work has been improving rigour and reproducibility in animal studies.
Good science can be lost in the final steps of an animal study. Poorly planned necropsies, inconsistent biosampling, unsuitable preservation or unclear scoring can compromise tissue-based data, waste animals and weaken reproducibility.
This webinar follows the pathology workflow from study design and clinical pathology sampling to necropsy, fixation, histology, assessment and reporting. Drawing on established recommendations for rigorous pathology practice and the MINPEPA reporting framework, Professor Jeffrey Everitt will examine where variability and bias arise, why pathology expertise should be involved early, and how study-specific protocols can improve consistency. The session will address tissue and fluid collection, preservation for morphological and molecular endpoints, lesion terminology and scoring, blinding, documentation, cost-conscious endpoint selection, and transparent reporting. Particular attention will be given to aligning methods with the scientific question and obtaining reliable information from each animal without unnecessary sampling or repeated studies.
Key references:
Scudamore CL, Soilleux EJ, Karp NA, et al. Recommendations for minimum information for publication of experimental pathology data: MINPEPA guidelines. Journal of Pathology. 2016;238:359–367.
Brayton CF, Boyd KL, Everitt JL, Meyerholz DK, Treuting PM, Bolon B. An Introduction to Pathology in Biomedical Research: A Mission-Critical Specialty for Reproducibility and Rigor in Translational Research. ILAR Journal. 59(1):1–3.
Everitt JI, Treuting PM, Scudamore C, et al. Pathology Study Design, Conduct, and Reporting to Achieve Rigor and Reproducibility in Translational Research Using Animal Models. ILAR Journal. 59(1):4–12.
Plan pathology input from the outset
Match sampling methods to study endpoints
Standardise necropsy and sample handling
Apply consistent scoring and bias controls
Report pathology data using MINPEPA principles
Pathology should inform study design
Necropsy is a critical one-time event
Preservation determines analytical possibilities
Standardisation limits variation and sample loss
Transparent reporting supports reproducibility